Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does ROSIGLITAZONE Cause Bundle branch block left? 35 Reports in FDA Database

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

According to the FDA Adverse Event Reporting System (FAERS), 35 reports of Bundle branch block left have been filed in association with ROSIGLITAZONE. This represents 0.1% of all adverse event reports for ROSIGLITAZONE.

35
Reports of Bundle branch block left with ROSIGLITAZONE
0.1%
of all ROSIGLITAZONE reports
1
Deaths
33
Hospitalizations

How Dangerous Is Bundle branch block left From ROSIGLITAZONE?

Of the 35 reports, 1 (2.9%) resulted in death, 33 (94.3%) required hospitalization.

Is Bundle branch block left Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for ROSIGLITAZONE. However, 35 reports have been filed with the FAERS database.

What Other Side Effects Does ROSIGLITAZONE Cause?

Myocardial infarction (17,018) Cardiac failure congestive (15,085) Cerebrovascular accident (7,899) Coronary artery disease (4,982) Acute myocardial infarction (2,437) Cardiac disorder (1,732) Coronary arterial stent insertion (1,698) Coronary artery bypass (1,181) Chest pain (990) Myocardial ischaemia (970)

What Other Drugs Cause Bundle branch block left?

SACUBITRIL\VALSARTAN (159) BISOPROLOL (111) PANTOPRAZOLE (96) ROSUVASTATIN (94) CARVEDILOL (92) FUROSEMIDE (90) AMIODARONE (87) SPIRONOLACTONE (84) CLOZAPINE (82) METFORMIN (80)

Which ROSIGLITAZONE Alternatives Have Lower Bundle branch block left Risk?

ROSIGLITAZONE vs ROSUVASTATIN ROSIGLITAZONE vs ROSUVASTATIN\ROSUVASTATIN ROSIGLITAZONE vs ROTIGOTINE ROSIGLITAZONE vs ROXADUSTAT ROSIGLITAZONE vs ROXICODONE

Related Pages

ROSIGLITAZONE Full Profile All Bundle branch block left Reports All Drugs Causing Bundle branch block left ROSIGLITAZONE Demographics